The campaign builds upon evidence from house-to-house administration of Inactivated Poliovirus in Nigeria which demonstrated needle-free, intradermal vaccine administration is easy-to-use and can ...

The MarketWatch News Department was not involved in the creation of this content. -- Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use ...

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...

Proprietary technology positioned to become the new standard of care in global drug delivery SANTA CLARA, Calif., Oct. 2, 2018 /PRNewswire/ -- Based on its recent analysis of the global drug delivery ...

GOLDEN, Colo. and CAIRO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology ...

PharmaJet has struck an agreement covering the use of its Tropis needle-free injection system in Nigeria, positioning vaccinators to deploy the technology in a project intended to tackle a poliovirus ...

GeoVax Zika Virus Vaccine Provided 100% Protection in Animal Challenge Model ATLANTA, GA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human ...

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that Marian Wentworth has been appointed to its Board of Directors. Ms. Wentworth, President and CEO of ...

The PharmaJet Tropis Intradermal (ID) Needle-free System will be used exclusively to deliver vaccine to 1.8 million children in upcoming campaign. To date, 12+ million pediatric injections have been ...

PharmaJet(R) , a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it has signed a Distribution ...